FAKTOR OPTIONSSCHEIN - INCYTE CO. Stock

DE000GG732D9

Real-time BOERSE MUENCHEN 03:00:40 2024-06-17 am EDT
38.34 ^EUR	+2.54%

Current month	+79.67%
1 month	+87.04%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

Incyte Insider Sold Shares Worth $1,149,840, According to a Recent SEC Filing	Jun. 14	MT
Incyte Reports Tender Offer Results	Jun. 13	MT
Incyte Announces Final Results of Tender Offer	Jun. 13	BU
Incyte Reports Preliminary Tender Offer Results	Jun. 11	MT

More news

Quotes 5-day view

Date	Price	Change
24-06-17	38.34	+2.54%
24-06-14	37.39	-13.65%
24-06-13	43.3	+58.55%
24-06-11	27.31	+2.06%
24-06-10	26.76	+2.37%

Real-time BOERSE MUENCHEN

Last update June 17, 2024 at 03:00 am EDT

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Goldman Sachs
WKN	GG732D
ISIN	DE000GG732D9
Date issued	2024-04-26
Strike	57.33 $
Maturity	Unlimited
Parity	0.12 : 1
Emission price	8.66 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	43.95 €
Lowest since issue	6.83 €
Spread	1 €
Spread %	2.53%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

62.11 USD

Average target price

72.8 USD

Spread / Average Target

+17.21%

Consensus